VDV Pharma
Timeline
11 events since 2020Filings
Financial
Establishments
2020202220242026
Deadline for the 2026 accounts: 31-01-2027
2025
Annual accounts 2025 filed PDFfull format · 75 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0750740804
Annual accounts 2024 filed PDFfull format · 24 days before the deadline
2024
Annual accounts 2023 filed PDFfull format · 8 days before the deadline
2023
Equity above €200,000 equity €248,442 ▲51.5% With a profit in every financial year since 2021, equity grows to €248,442.
2022
Annual accounts 2022 filed PDFmicro format · 50 days before the deadline
Highest result from 2021 to 2025 net €122,117 ▲624% The operating result of €162,455 and the net result of €122,117 are both a record.
Equity above €150,000 equity €163,976 ▲292% With a profit in every financial year since 2021, equity grows to €163,976.
Annual accounts 2021 filed PDFmicro format · 27 days before the deadline
2020
First establishment Helmetsesteenweg 373, Schaerbeek
IncorporationFounding capital of €25,000, 100 shares · Founder: PYLS Julie, Désirée, Fabienne · Appointment: PYLS Julie, Désirée, Fabienne (director) · published on 20-07-20204 points ▸
- Founder, PYLS Julie, Désirée, Fabienne
- Founding capital, €25,000, 100 shares
- Registered office clause, chaussée de Helmet 373, 1030 Schaerbeek
- Director appointment, PYLS Julie, Désirée, Fabienne
- The deed holds 18 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
VDV Pharma was incorporated on 16 July 2020 as a private limited company by one natural person, with a starting capital of €25,000.12 PYLS Julie,Désirée,Fabienne is director of the company, appointed by deed of 20-07-2020.2 Total assets rose from €422,453 in 2021 to €1.5m in 2025 and headcount from 0.9 to 1.5 full-time equivalents.3